Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Solid Tumor and Lymphoma Malignancies × TAK-659 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma 2 Leukemia, Myeloid, Acute 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Ovarian Neoplasms 1 Lymphoma, Follicular 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Solid Tumor and Lymphoma Malignancies 1 Advanced Solid Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02000934 2023-02-08

A Study of TAK-659 in Adult Participants With Advanced Solid Tumor and Lymphoma Malignancies

Calithera Biosciences, Inc

Phase 1 Completed

LymphoidOther solid neoplasm

Advanced Solid Tumor and Lymphoma Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡